Better protection against meningococcal and pneumococcal diseases

6 July 2020 - The National Immunisation Program has been amended from 1 July 2020 to improve protection for those most ...

Read more →

PBS listings to benefit Australians with type 2 diabetes and small cell lung cancer, emergency dispensing measures of PBS medicines extended

30 June 2020 - The importance of the Pharmaceutical Benefits Scheme has been underlined with new and amended medicines listings on ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2020

1 July 2020 - The July 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 July 2020

1 July 2020 - The July 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Summary of PBS opioid listings for the treatment of pain as of 1 June 2020

2 June 2020 - A number of changes were made to the PBS listings for opioid medicines for the treatment of ...

Read more →

Estimating the cost of delayed generic drug entry to Medicaid

1 June 2020 - Delays in market entry of generic drugs are common.  ...

Read more →

Expanded PBS medicines listings to provide new treatment options for over 170,000 asthmatics, and new hope for blood cancer patients

1 June 2020 - Australians with asthma and multiple myeloma will have broader access to life changing medicines as a result ...

Read more →

Schedule of Pharmaceutical Benefits - 1 June 2020

1 June 2020 - The June 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Greater flexibility for Australians with severe asthma with reimbursement of at-home

1 June 2020 - Greater flexibility for Australians with severe asthma with reimbursement of at-home, self-administration delivery of Nucala (mepolizumab) ...

Read more →

New Zealand Pharmaceutical Schedule - 1 June 2020

1 June 2020 - The June 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

New biosimilar trastuzumab on the PBS - information for health professionals and patients

26 May 2020 - A biosimilar brand of trastuzumab (Trazimera) was listed on the PBS on 1 May 2020.  ...

Read more →

Proposal to award sole supply of infliximab in DHB hospitals

21 May 2020 - PHARMAC is proposing to award sole supply of infliximab, a biologic medicine used to treat a ...

Read more →

Atomoxetine – further delay in change of funded brand and open access

20 May 2020 - PHARMAC is advising all interested parties that there is a further one-month delay in the listing ...

Read more →

Japan OKs public insurance coverage for SMA drug Zolgensma

13 May 2020 - A panel that advises the health minister approved on Wednesday coverage for Novartis' spinal muscular atrophy ...

Read more →

New listings welcomed amongst COVID backdrop

4 May 2020 - Medicines Australia welcomes Friday’s announcement by Minister for Health the Hon Greg Hunt on the PBS ...

Read more →